The United States Food and Drug Administration’s (USFDA’s) Pregnancy, Lactation and Labeling Rule (PLLR), which came into effect in June 2015, establishes a labeling standard for prescription drug products which can be used during maternity and lactation. In addition, to overcome the current prescription drug labeling information, the new rule focuses more on content and format changes under Physician Labeling Rule (PLR), too.
















